+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Computational Biology Market by Product Type, Technology, Application, End User - Global Forecast to 2030- Product Image
Computational Biology Market by Product Type, Technology, Application, End User - Global Forecast to 2030- Product Image
Sale

Computational Biology Market by Product Type, Technology, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4896509
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Computational Biology Market grew from USD 7.42 billion in 2024 to USD 8.86 billion in 2025. It is expected to continue growing at a CAGR of 18.96%, reaching USD 21.05 billion by 2030.

Unlocking the Power of Computational Biology

Computational biology has emerged as a cornerstone of modern life sciences, driving innovation across drug discovery, diagnostics, and precision medicine. By integrating algorithms, high-throughput data, and advanced analytics, this multidisciplinary field deciphers complex biological mechanisms at unprecedented scale. Leaders in biotechnology, pharmaceuticals, and academia are leveraging computational models to accelerate research timelines, improve experimental reproducibility, and unlock novel therapeutic targets.

This executive summary synthesizes the latest trends, regulatory dynamics, and competitive strategies shaping the computational biology ecosystem. It offers decision-makers a clear lens on transformative technologies, the impact of evolving trade policies, and actionable recommendations for navigating a fragmented yet high-potential market. As stakeholders seek to harness big data in genomics, proteomics, and imaging, understanding these insights will prove essential to secure sustainable growth and maintain a competitive edge.

Revolutionary Forces Redefining Computational Biology

The landscape of computational biology has undergone seismic shifts propelled by breakthroughs in artificial intelligence, cloud-native infrastructure, and multi-omics integration. Machine learning algorithms now automate complex pattern recognition in genomics, enabling accurate variant calling and functional annotation without extensive manual intervention. Meanwhile, the proliferation of single-cell technologies has generated granular datasets that demand scalable computational pipelines to reconstruct cellular differentiation trajectories and disease pathways.

Cloud computing has democratized access to high-performance computing resources, allowing researchers to run sophisticated simulations and neural network training at scale. Open-source platforms and collaborative data repositories are dismantling siloes, fostering cross-institutional validation of predictive models. Concurrently, the maturation of CRISPR-based screening has spurred the creation of in silico design tools that optimize guide RNA specificity and off-target minimization. These converging forces are transforming R&D workflows, reducing experimental attrition rates, and accelerating the translation of computational insights into clinical applications.

Unpacking the 2025 US Tariffs on Computational Biology Markets

Beginning in early 2025, newly implemented United States tariffs on imported laboratory instruments, reagents, and software have created material headwinds for the computational biology market. Equipment such as sequencing instruments, mass spectrometers, and advanced imaging systems now carry additional duties, increasing overall acquisition costs for academic institutions, contract research organizations, and corporate R&D centers. This price escalation has prompted many end users to defer capital expenditure or reallocate budgets toward lower-cost alternatives.

Reagents and consumables used in library preparation, proteomics assays, and PCR workflows have seen cost inflation, compelling procurement teams to negotiate volume discounts and explore domestic suppliers. Software licensing and maintenance services are also affected, as vendors adjust pricing structures to offset tariff-related margin pressures. In response, several multinational providers have initiated local manufacturing partnerships and supply chain reconfigurations to mitigate cost disruptions. Directors of research are now balancing the imperative to maintain cutting-edge capabilities with tighter budget constraints, driving a nuanced procurement strategy that blends tariff-free domestic sourcing with selective foreign investment.

Dissecting Market Dynamics through Strategic Segmentation

Segmentation by product type reveals that instruments remain the principal revenue driver, with imaging systems encompassing confocal, electron, and fluorescence modalities, alongside mass spectrometry and sequencing platforms that continue to command premium pricing. Reagents and consumables contribute recurring revenue through library preparation kits, PCR reagents, and specialized proteomics and sequencing reagents. Meanwhile, software and services, spanning bioinformatics consulting, data analysis platforms, and instrument maintenance contracts, underpin long-term customer relationships and service-based business models.

When examined by technology, next-generation sequencing dominates in terms of dataset generation, with Illumina, Ion Torrent, and Oxford Nanopore chemistries addressing different throughput and read-length requirements. Digital and quantitative PCR systems maintain strong adoption in targeted applications, while microarrays for DNA and protein analysis provide cost-effective screening solutions. Core imaging systems and mass spectrometry variants such as ESI-MS and MALDI-TOF support multiplexed assays, fueling demand in both research and diagnostic segments.

Application-level insights indicate diagnostics-spanning cancer screening, genetic testing, and infectious disease surveillance-drive substantial spending on computational workflows. Drug discovery sectors leverage in silico target identification, lead optimization, and toxicity screening to streamline pipelines, while genomic analysis services in DNA sequencing, epigenetics, and RNA sequencing expand academic and clinical offerings. Proteomic analysis further diversifies with protein identification, post-translational modification mapping, and quantitative proteomics tools.

End-user segmentation highlights that academic and government research institutes, including major universities, maintain robust funding for hypothesis-driven studies, whereas large contract research organizations focus on scalable service delivery. Hospitals and independent diagnostic laboratories deploy computational tools for rapid turnaround of clinical assays, and pharmaceutical and biotechnology companies integrate data-driven R&D to accelerate pipeline advancement and regulatory submissions.

Regional Market Trends Shaping Computational Biology Growth

In the Americas, strong healthcare infrastructure and R&D investments in the United States and Canada underpin early adoption of cutting-edge computational biology solutions. Government funding for genomics initiatives and public-private partnerships accelerates translational research, while private equity inflows into biotech startups stimulate entrepreneurial ecosystems. Cross-border collaborations with Latin American research centers are emerging, leveraging regional expertise in tropical disease genomics and population studies.

Europe, Middle East & Africa markets are characterized by heterogeneity in regulatory frameworks and healthcare expenditure. The European Union’s emphasis on data privacy and interoperability has driven the development of federated data analysis platforms, enabling secure multi-center studies. In the Middle East, sovereign wealth funds are financing genomic medicine programs, whereas African centers are increasing capacity for infectious disease surveillance through collaborative networks supported by international grants.

Asia-Pacific exhibits one of the fastest growth rates, propelled by national initiatives in China, Japan, South Korea, and India that prioritize precision medicine and agricultural biotech. Large sequencing centers are scaling operations through public funding, while private sector players expand downstream services in bioinformatics and software development. Regulatory authorities are streamlining approval pathways for companion diagnostics, catalyzing demand for integrated computational workflows across clinical and preclinical settings.

Competitive Landscape and Leading Innovators

Leading providers in computational biology are differentiating through integrated hardware-software ecosystems and strategic partnerships with cloud service providers. Thermo Fisher Scientific continues to expand its portfolio through acquisitions of specialized software firms, enhancing end-to-end data management capabilities. Illumina maintains market leadership in sequencing by introducing higher-throughput flow cells and AI-enhanced base-calling algorithms that improve accuracy and reduce per-sample costs.

Bio-Rad Laboratories and QIAGEN focus on strengthening reagent and consumables pipelines, leveraging proprietary chemistries for library preparation and single-cell workflows. Agilent Technologies and Bruker Corporation invest in mass spectrometry and imaging innovations, targeting applications in metabolomics and structural biology. Emerging players offering niche bioinformatics platforms and consulting services are carving out differentiated positions by embedding machine learning models tailored to specific disease areas, while larger CROs are integrating data analytics offerings to enhance customer value propositions.

Strategic Imperatives for Industry Trailblazers

To capitalize on the expanding computational biology market, industry leaders should forge collaborative alliances between instrument manufacturers and cloud providers to deliver seamless, scalable analytics solutions. They must prioritize the development of standardized, interoperable data formats to reduce integration costs and accelerate cross-platform compatibility. Investment in AI-driven automation will not only enhance throughput but also enable real-time QA/QC, optimizing experimental success rates and resource utilization.

Organizations are advised to diversify supply chains by establishing regional manufacturing nodes and reagent production hubs, mitigating the impact of unpredictable tariffs and trade barriers. Cultivating talent through specialized training programs in bioinformatics and data science will address the widening skills gap. Finally, companies should engage proactively with regulatory bodies to shape forward-looking policies on data privacy, cloud-based diagnostics, and AI validation, ensuring smooth market entry for innovative solutions.

Rigorous Approach to Market Intelligence Gathering

This analysis draws upon a dual-track research framework combining extensive primary interviews with senior R&D directors, procurement leads, and academic thought leaders alongside comprehensive secondary research, including peer-reviewed publications, patent filings, regulatory databases, and corporate filings. Market segmentation insights were validated through data triangulation, reconciling vendor revenue disclosures with shipment volume statistics and end-user surveys.

Quantitative models were developed using statistical regression and time-series analysis to identify correlations between technology adoption rates and regional funding patterns. Qualitative insights emerged from thematic coding of interview transcripts, highlighting use-case validation and unmet needs. Rigorous quality control measures, including peer review and expert advisory consultations, ensure that the findings presented here reflect the latest industry developments and maintain methodological transparency.

Synthesizing Insights for Informed Decision Making

As computational biology continues to unlock new frontiers in life sciences, stakeholders equipped with a nuanced understanding of market disruptors, segmentation drivers, and regional dynamics will gain a decisive competitive advantage. Addressing tariff-related cost pressures, aligning product portfolios with emerging application demands, and fostering strategic partnerships will be pivotal in capturing growth opportunities.

By integrating these insights, decision-makers can optimize R&D investments, streamline supply chain strategies, and accelerate the translation of computational discoveries into commercial and clinical success. This executive summary sets the stage for more detailed analysis and supports informed planning for the evolving computational biology landscape.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Instruments
      • Imaging Systems
      • Mass Spectrometry Instruments
      • Microarray Scanners
      • PCR Instruments
      • Sequencing Instruments
    • Reagents & Consumables
      • Library Prep Reagents
      • PCR Reagents
      • Proteomics Reagents
      • Sequencing Reagents
    • Software & Services
      • Bioinformatics Services
      • Data Analysis Software
      • Instrument Maintenance Services
  • Technology
    • Imaging Systems
      • Confocal Microscopy
      • Electron Microscopy
      • Fluorescence Imaging
    • Mass Spectrometry
      • ESI-MS
      • MALDI-TOF
    • Microarray
      • DNA Microarray
      • Protein Microarray
    • Next Gen Sequencing
      • Illumina Sequencing
      • Ion Torrent Sequencing
      • Oxford Nanopore Sequencing
    • PCR
      • Digital PCR
      • qPCR
  • Application
    • Diagnostics
      • Cancer Diagnostics
      • Genetic Testing
      • Infectious Disease
    • Drug Discovery
      • Lead Optimization
      • Target Identification
      • Toxicity Screening
    • Genomic Analysis
      • DNA Sequencing
      • Epigenetic Analysis
      • RNA Sequencing
    • Proteomic Analysis
      • Protein Identification
      • PTM Analysis
      • Quantitative Proteomics
  • End User
    • Academic & Research Institutes
      • Government Research Centers
      • Universities
    • Contract Research Organizations
      • Large CROs
      • Niche CROs
    • Hospitals & Diagnostic Laboratories
      • Hospital Laboratories
      • Independent Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
      • Biotechnology Companies
      • Pharmaceutical Companies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • QIAGEN N.V.
  • Roche Holding AG
  • PerkinElmer Inc.
  • Agilent Technologies Inc.
  • BGI Genomics Co., Ltd.
  • DNAnexus Inc.
  • Seven Bridges Genomics Inc.
  • Genestack Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Computational Biology Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Imaging Systems
8.2.2. Mass Spectrometry Instruments
8.2.3. Microarray Scanners
8.2.4. PCR Instruments
8.2.5. Sequencing Instruments
8.3. Reagents & Consumables
8.3.1. Library Prep Reagents
8.3.2. PCR Reagents
8.3.3. Proteomics Reagents
8.3.4. Sequencing Reagents
8.4. Software & Services
8.4.1. Bioinformatics Services
8.4.2. Data Analysis Software
8.4.3. Instrument Maintenance Services
9. Computational Biology Market, by Technology
9.1. Introduction
9.2. Imaging Systems
9.2.1. Confocal Microscopy
9.2.2. Electron Microscopy
9.2.3. Fluorescence Imaging
9.3. Mass Spectrometry
9.3.1. ESI-MS
9.3.2. MALDI-TOF
9.4. Microarray
9.4.1. DNA Microarray
9.4.2. Protein Microarray
9.5. Next Gen Sequencing
9.5.1. Illumina Sequencing
9.5.2. Ion Torrent Sequencing
9.5.3. Oxford Nanopore Sequencing
9.6. PCR
9.6.1. Digital PCR
9.6.2. qPCR
10. Computational Biology Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Cancer Diagnostics
10.2.2. Genetic Testing
10.2.3. Infectious Disease
10.3. Drug Discovery
10.3.1. Lead Optimization
10.3.2. Target Identification
10.3.3. Toxicity Screening
10.4. Genomic Analysis
10.4.1. DNA Sequencing
10.4.2. Epigenetic Analysis
10.4.3. RNA Sequencing
10.5. Proteomic Analysis
10.5.1. Protein Identification
10.5.2. PTM Analysis
10.5.3. Quantitative Proteomics
11. Computational Biology Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.2.1. Government Research Centers
11.2.2. Universities
11.3. Contract Research Organizations
11.3.1. Large CROs
11.3.2. Niche CROs
11.4. Hospitals & Diagnostic Laboratories
11.4.1. Hospital Laboratories
11.4.2. Independent Diagnostic Laboratories
11.5. Pharmaceutical & Biotechnology Companies
11.5.1. Biotechnology Companies
11.5.2. Pharmaceutical Companies
12. Americas Computational Biology Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Computational Biology Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Computational Biology Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Illumina Inc.
15.3.3. QIAGEN N.V.
15.3.4. Roche Holding AG
15.3.5. PerkinElmer Inc.
15.3.6. Agilent Technologies Inc.
15.3.7. BGI Genomics Co., Ltd.
15.3.8. DNAnexus Inc.
15.3.9. Seven Bridges Genomics Inc.
15.3.10. Genestack Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. COMPUTATIONAL BIOLOGY MARKET MULTI-CURRENCY
FIGURE 2. COMPUTATIONAL BIOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. COMPUTATIONAL BIOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. COMPUTATIONAL BIOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. COMPUTATIONAL BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COMPUTATIONAL BIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SEQUENCING INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY LIBRARY PREP REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMICS REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SEQUENCING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENT MAINTENANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONFOCAL MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ELECTRON MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY FLUORESCENCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ESI-MS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ILLUMINA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ION TORRENT SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY OXFORD NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY TOXICITY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY EPIGENETIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEIN IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PTM ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY QUANTITATIVE PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY LARGE CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY NICHE CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 128. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 130. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 131. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 132. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 134. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 135. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 136. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2030 (USD MILLION)
TABLE 137. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 138. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 140. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 141. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 142. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 143. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 145. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 146. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 147. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 148. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 150. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 151. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 152. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 154. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 155. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 156. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2030 (USD MILLION)
TABLE 157. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 158. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 160. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 161. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 165. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 166. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 167. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 195. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 196. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2030 (USD MILLION)
TABLE 197. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 198. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 200. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 201. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 202. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 203. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 205. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 206. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 207. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 246. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 248. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 249. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 251. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 252. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 253. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 255. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 256. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 257. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2030 (USD MILLION)
TABLE 258. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 259. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 261. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 262. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 263. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 264. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 266. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 267. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 268. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 269. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 271. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 272. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 273. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 275. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 276. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 277. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2030 (USD MILLION)
TABLE 278. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 279. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 281. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 282. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 283. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 284. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 286. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 287. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 288. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 289. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 291. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 292. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 293. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY GENOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PROTEOMIC ANALYSIS, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 308. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 309. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 311. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 312. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 313. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 315. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 316. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY MICROARRAY,

Companies Mentioned

The companies profiled in this Computational Biology market report include:
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • QIAGEN N.V.
  • Roche Holding AG
  • PerkinElmer Inc.
  • Agilent Technologies Inc.
  • BGI Genomics Co., Ltd.
  • DNAnexus Inc.
  • Seven Bridges Genomics Inc.
  • Genestack Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 21.05 Billion
Compound Annual Growth Rate18.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Computational Biology Market Report by Application, Services, End Use, and Region 2024-2032 - Product Image

Computational Biology Market Report by Application, Services, End Use, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Computational Biology - Global Strategic Business Report - Product Image

Computational Biology - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Computational Biology Market Report 2025 - Product Image

Computational Biology Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Computational Biology Market Report and Forecast 2024-2032 - Product Image

Computational Biology Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Research & Reviews: Journal of Computational Biology - Product Image

Research & Reviews: Journal of Computational Biology

  • Journal Icon Journal
  • 62 Pages
  • Global
From

About the Computational Biology Market

Computational Biology is a field of study that combines the principles of computer science and biology to analyze and interpret biological data. It is closely related to bioinformatics, which is the application of computer and information technology to the management of biological data. Computational Biology is used to study the structure and function of biological systems, such as proteins, DNA, and cells. It is also used to develop new methods for analyzing and interpreting biological data. The Computational Biology market is growing rapidly, driven by the increasing demand for data-driven solutions in the life sciences. This market is expected to continue to grow as more organizations adopt computational biology techniques to gain insights into biological systems. Some companies in the Computational Biology market include Illumina, Thermo Fisher Scientific, BGI, and Qiagen. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.